Table 2.
A summary of clinical and demographic data for patients included in the third-test analysis (N=6813).
| Characteristic | Value | |
| Symptomatic rate (%), mean (SD) | 87.3 (32.8) | |
| Age group (years), n (%) | ||
|
|
Adult (18-64) | 5237 (76.9) |
|
|
Child (<18) | 452 (6.6) |
|
|
Older adult (>65) | 1124 (16.5) |
| Race, n (%) | ||
|
|
White | 2689 (39.5) |
|
|
American Indian or Alaska Native | 41 (0.6) |
|
|
Asian | 477 (7) |
|
|
Black or African American | 1560 (22.9) |
|
|
Native Hawaiian or Other Pacific Islander | 41 (0.6) |
|
|
Not reported | 1675 (24.6) |
|
|
Other | 330 (4.8) |
| Ethnicity, n (%) | ||
|
|
Not Hispanic/Latino | 4465 (65.5) |
|
|
Hispanic/Latino | 1480 (21.7) |
|
|
Not reported | 868 (12.7) |
| Region, n (%) | ||
|
|
Northeast | 1570 (23) |
|
|
Midwest | 1116 (16.4) |
|
|
Other/Unspecified | 1 (0.0) |
|
|
South | 3202 (47) |
|
|
West | 924 (13.6) |
| Sex, n (%) | ||
|
|
Male | 2844 (41.7) |
|
|
Female | 3939 (57.8) |
|
|
Undetermined | 30 (0.4) |
| Insurance Status, n (%) | ||
|
|
Private insurance | 3812 (56) |
|
|
Cash | 33 (0.5) |
|
|
HRSAa | 15 (0.2) |
|
|
Medicaid | 842 (12.4) |
|
|
Medicare | 846 (12.4) |
|
|
Uninsured | 1265 (18.6) |
| Site Contractor, n (%) | ||
|
|
CVS | 6664 (97.8) |
|
|
eTrueNorth | 6 (0.1) |
|
|
Walgreens | 143 (2.1) |
| Year quarter, n (%) | ||
|
|
2022Q3 | 1906 (28) |
|
|
2022Q4 | 1738 (25.5) |
|
|
2023Q1 | 1694 (24.9) |
|
|
2023Q2 | 473 (6.9) |
|
|
2023Q3 | 419 (6.2) |
|
|
2023Q4 | 212 (3.1) |
|
|
2024Q1 | 149 (2.2) |
|
|
2024Q2 | 62 (0.9) |
|
|
2024Q3 | 126 (1.8) |
|
|
2024Q4 | 31 (0.5) |
|
|
2025Q1 | 3 (0.0) |
aHRSA: Health Resources and Services Administration.